on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released a Form 8.3 concerning its interests in Mural Oncology plc, aligning with Rule 8.3 of the Irish Takeover Panel Act, 1997. As of May 5, 2025, The Vanguard Group holds a 4.47% interest in Mural Oncology, equating to 772,651 ordinary shares.
No new options or derivative transactions related to this investment have been made, and there are no associated agreements, arrangements, or understandings. This disclosure does not involve other parties or exempt fund manager connections, focusing solely on interests in Mural Oncology plc.
With no additional attachments or dealings reported, this disclosure is intended to inform stakeholders of The Vanguard Group's position within the scope of ongoing market operations.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news